UTA FAMILY 3 FINAL EXAM LATEST ACTUAL EXAM TEST 2025 WITH LATEST UPDATED (QUESTIONS AND ANSWERS) /ALREADY GRADED A+

UTA FAMILY 3 FINAL EXAM LATEST ACTUAL EXAM TEST 2025
WITH LATEST UPDATED (QUESTIONS AND ANSWERS) /ALREADY
GRADED A+


2017 ACC/AHA guidelines: normal BP ✓ <120 / <80




2017 ACC/AHA guidelines: elevated BP ✓ 120-129/ <80




2017 ACC/AHA guidelines: stage 1 HTN ✓ 130--89




2017 ACC/AHA guidelines: stage 2 HTN ✓ ≥ 140/ ≥ 90




What is recommended for white coat ✓ - lifestyle modification

hypertension? - annual ABPM or HBPM


What is recommended for masked ✓ - lifestyle modification

hypertension? - start HTN medication

,What is recommended for elevated BP? ✓ - lifestyle modification

- annual ABPM


What is secondary hypertension? ✓ - drug resistant/induced

hypertension

- exacerbation of previously

controlled hypertension

- accelerated/malignant

hypertension

- unprovoked or excessive

hypokalemia

What are common causes of secondary ✓ - renal disease

hypertension? - aldosteronism

- OSA

- drug and alcohol induced

What are non-pharmacological interventions ✓ - weight loss

for hypertension? - DASH diet

- sodium reduction

- potassium supplementation

- reduce alcohol consumption

2017 ACC/AHA guidelines: clinical CVD and ✓ use BP lowering meds

BP ≥ 130 / ≥ 80

, 2017 ACC/AHA guidelines: primary ✓ use BP lowering meds

prevention in adults 10 yr ASCVD risk of ≥

10%

2017 ACC/AHA guidelines: 10 yr risk < 10% ✓ use BP lowering meds

and SBP ≥ 140/90


2017 ACC/AHA guidelines: normal BP ✓ yearly

reassessment


2017 ACC/AHA guidelines: elevated BP ✓ 3-6 months

reassessment


2017 ACC/AHA guidelines: stage 1 HTN ✓ 3-6 months

reassessment and 10 yr ASCVD < 10%


2017 ACC/AHA guidelines: stage 2 HTN ✓ one month until goal BP met, then

reassessment 3-6 months


2017 ACC/AHA guidelines: stage 1 HTN ✓ one month until BP goal met, then

reassessment and 10 yr ASCVD > 10% 3-6 months


What hypertensive medications should not ✓ - ACE

be prescribed simultaneously? - ARB

- Renin Inhibitor